Parsippany-based Compass340B on Monday announced Teri Hart-Coney, previously serving as the company’s president, will assume the dual role of CEO and chief operating officer, effective immediately.
In her new appointment, Hart-Coney will oversee the company’s strategic direction and operational functions, leveraging her extensive industry knowledge to drive continued growth and success.
“I am honored to assume the dual role of CEO and COO at Compass340B,” Hart-Coney said. “As we navigate an evolving health care and 340B (drug pricing program) landscape, I am committed to leading our talented team towards even greater heights of innovation and service excellence. Together, we will continue to deliver unparalleled value to our clients and business partners.”
This leadership update marks an exciting chapter for Compass340B, as the company continues to innovate and expand its suite of offerings to meet the evolving needs of 340B providers across the nation.
Compass340B is a provider of comprehensive 340B program consulting, audit, program management and software solutions, dedicated to helping health care organizations optimize their 340B programs with an unwavering commitment to innovation and service excellence.
